Survival benefits of postoperative radiotherapy in esophageal cancer during the immunotherapy era:a retrospective cohort study based on the SEER database and a single-center registry in China
The collaborative effect of immunotherapy and PORT potentially enhances survival outcomes for patients with EC. However, further prospective research is essential to confirm our results.
Authors
- Muhong Wang
- Chunbo Wang (ORCID: https://orcid.org/0000-0002-1685-2190)
- Yuxin Mao (ORCID: https://orcid.org/0000-0002-5064-1397)
- Jiaqi Gu (ORCID: https://orcid.org/0000-0002-4644-6046)
- X. Zhang (ORCID: https://orcid.org/0000-0002-4381-6822)
- Jingyi Wang (ORCID: https://orcid.org/0000-0002-0423-6868)
- Qian Zhang (ORCID: https://orcid.org/0000-0003-4928-3366)
- Jin Zhang (ORCID: https://orcid.org/0000-0002-2566-7501)
- Shuyang Chen (ORCID: https://orcid.org/0000-0003-2627-3691)
- Yingying Zhu (ORCID: https://orcid.org/0000-0002-2543-4476)
- Yang Cao (ORCID: https://orcid.org/0000-0002-3318-4921)
- Jia‐Tao Zhang (ORCID: https://orcid.org/0000-0003-4302-9332)
Institutions
- Harbin Medical University (CN)
- Wenzhou Medical University (CN)
- Third Affiliated Hospital of Harbin Medical University (CN)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2025-02-24
- DOI
- https://doi.org/10.3389/fimmu.2025.1548520
- Citations
- 2
- Primary Topic
- Esophageal Cancer Research and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 4.01